"The U.S. Food and Drug Administration today approved Vizamyl (flutemetamol F 18 injection), a radioactive diagnostic drug for use with positron emission tomography (PET) imaging of the brain in adults being evaluated for Alzheimer's disease (AD) "...
- Instruct patients to inform their physician or healthcare provider if they are pregnant or breastfeeding.
- Inform patients who are breastfeeding to use alternate infant nutrition sources (e.g. stored breast milk or infant formula) for 24 hours ( > 10 half-lives of radioactive decay for the F 18 isotope) after administration of the drug or to avoid use of the drug.
Last reviewed on RxList: 3/31/2014
This monograph has been modified to include the generic and brand name in many instances.
Additional Neuraceq Information
Report Problems to the Food and Drug Administration
Get breaking medical news.